Cargando…
Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
The recent successes in the use of immunotherapy to treat cancer have led to a multiplicity of new compounds in development. Novel clinical-grade biomarkers are needed to guide the choice of these agents to obtain the maximal likelihood of patient benefit. Predictive biomarkers for immunotherapy dif...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874671/ https://www.ncbi.nlm.nih.gov/pubmed/29393888 http://dx.doi.org/10.3390/biomedicines6010014 |